Credit Suisse Group Analysts Give Gerresheimer AG (GXI) a €80.00 Price Target

Gerresheimer AG (ETR:GXI) has been assigned a €80.00 ($94.12) price objective by analysts at Credit Suisse Group in a research report issued on Tuesday. The firm currently has a “buy” rating on the stock.

A number of other research firms also recently weighed in on GXI. Independent Research GmbH set a €78.00 ($91.76) target price on Gerresheimer AG and gave the stock a “neutral” rating in a report on Wednesday, July 19th. DZ Bank AG reissued a “buy” rating on shares of Gerresheimer AG in a report on Monday, July 17th. J P Morgan Chase & Co set a €99.40 ($116.94) target price on Gerresheimer AG and gave the stock a “buy” rating in a report on Monday, July 17th. Hauck & Aufhaeuser set a €80.00 ($94.12) target price on Gerresheimer AG and gave the stock a “neutral” rating in a report on Friday, July 14th. Finally, Deutsche Bank AG set a €82.00 ($96.47) target price on Gerresheimer AG and gave the stock a “buy” rating in a report on Friday, July 14th. One research analyst has rated the stock with a sell rating, five have given a hold rating and five have given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of €72.94 ($85.81).

Gerresheimer AG (ETR:GXI) opened at 64.561 on Tuesday. Gerresheimer AG has a 52 week low of €59.97 and a 52 week high of €79.47. The firm has a market cap of €2.03 billion and a PE ratio of 17.884. The stock has a 50 day moving average of €65.44 and a 200-day moving average of €70.53.

ILLEGAL ACTIVITY WARNING: “Credit Suisse Group Analysts Give Gerresheimer AG (GXI) a €80.00 Price Target” was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this news story can be viewed at https://ledgergazette.com/2017/10/10/credit-suisse-group-analysts-give-gerresheimer-ag-gxi-a-80-00-price-target.html.

Gerresheimer AG Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic prod

A number of other research firms also recently weighed in on GXI. Independent Research GmbH set a €78.00 ($91.76) target price on Gerresheimer AG and gave the stock a “neutral” rating in a report on Wednesday, July 19th. DZ Bank AG reissued a “buy” rating on shares of Gerresheimer AG in a report on Monday, July 17th. J P Morgan Chase & Co set a €99.40 ($116.94) target price on Gerresheimer AG and gave the stock a “buy” rating in a report on Monday, July 17th. Hauck & Aufhaeuser set a €80.00 ($94.12) target price on Gerresheimer AG and gave the stock a “neutral” rating in a report on Friday, July 14th. Finally, Deutsche Bank AG set a €82.00 ($96.47) target price on Gerresheimer AG and gave the stock a “buy” rating in a report on Friday, July 14th. One research analyst has rated the stock with a sell rating, five have given a hold rating and five have given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of €72.94 ($85.81).

Gerresheimer AG (ETR:GXI) opened at 64.561 on Tuesday. Gerresheimer AG has a 52 week low of €59.97 and a 52 week high of €79.47. The firm has a market cap of €2.03 billion and a PE ratio of 17.884. The stock has a 50 day moving average of €65.44 and a 200-day moving average of €70.53.

ILLEGAL ACTIVITY WARNING: “Credit Suisse Group Analysts Give Gerresheimer AG (GXI) a €80.00 Price Target” was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this news story can be viewed at https://ledgergazette.com/2017/10/10/credit-suisse-group-analysts-give-gerresheimer-ag-gxi-a-80-00-price-target.html.

Gerresheimer AG Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer AG (ETR:GXI)

Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply